baber/WOPTO huggingface dataset:
Patent DE-69128873-D1 (DE)
Inventor: KURONO MASAYASU
IPC: C12Q1/28
Filed: 1991-11-27
Granted: 1998-03-12
Abstract: There are described a method of enzymatically measuring hydrogen peroxide by developing a color with use of 3-methyl-2-benzothiazolinonehydrazone as a coupler and in combination of an oxidative color developing reagent with peroxidase, and a reagent therefor. In case of the color developing reaction is carried out in a neutral or weak alkali pH condition, 3-methyl-2-benzothiazolinonehydrazone reagent containing catalase is used, and the reaction is carried out in the presence of ethylenediaminetetraacetic acid or its analogue. The reagent comprises a buffer, 3-methyl-2-benzothiazolinohydrazone, and catalase.
Patent DE-69129207-D1 (DE)
Inventor: MARTIN JACQUES
IPC: C07K14/155
Filed: 1991-01-11
Granted: 1998-05-14
Abstract: Peptides which issue from the glycoprotein envelope of the HIV virus and corresponding to one of the following formulae: X-Arg-Ile-Leu-Ala-Val-Glu-Arg-Tyr-Leu-Lys-Asp-Gln-Gln-Leu-Leu-Gly-Ile- Trp-Gly-Cys-Ser-Gly-Lys-Leu-Ile-Cys-Z (I> X-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys- Ala-Phe-Arg-Gln-Val-Cys-Z (II> in which X represents an NH2 group which is free or aminated by one or two alkyl groups comprising 1 to 5 carbon atoms, and Z represents either a free OH or alkoxy group, containing in the latter case an alkyl group comprising 1 to 5 carbon atoms, and in which at least one of the Cys residues is deleted, substituted or protected. Use in the detection of an infection due to HIV-1 and/or HIV-2 virus and in vaccination against AIDS.
Patent DE-69200445-D1 (DE)
Inventor: MABILE MICHEL
IPC: G01N21/76
Filed: 1992-01-27
Granted: 1994-10-27
Abstract: PCT No. PCT/FR92/00069 Sec. 371 Date Jul. 28, 1993 Sec. 102(e) Date Jul. 28, 1993 PCT Filed Jan. 27, 1992 PCT Pub. No. WO92/13264 PCT Pub. Date Aug. 6, 1992.The present invention relates to a method employing at least one luminescent tracer compound and a luminescent compound used as an internal reference, which, when exposed to the same excitation wavelength, are capable of emitting at difference wavelengths,  lambda 2 and  lambda 1 respectively, either by direct luminescence or by the induction of a luminescent emission, and correcting the measurement of the luminescence emitted by the tracer compound at wavelength  lambda 2 on the basis of the measurement of the luminescence emitted by the reference compound at wavelength  lambda 1.
Patent DE-69202716-D1 (DE)
Inventor: AESCHBACH ROBERT
IPC: A23L27/10
Filed: 1992-02-14
Granted: 1995-07-06
Abstract: The invention relates to a process for making an oxidation inhibiting liquid extract in which an extract of the spice obtained from a polar solvent is mixed with a saturated oil, the polar solvent is evaporated, non-polar solvent is added to the paste thus obtained, the mixture is homogenised, the precipitate is separated and the non- polar solvent is evaporated to obtain a clear oil of oxidation inhibiting extract.
Patent DE-69203279-D1 (DE)
Inventor: CLARK LEE
IPC: G01D5/30
Filed: 1992-04-24
Granted: 1995-08-10
Abstract: Position, velocity and direction of movement of a linear motor is determined by a fiberoptic encoder comprised of first and second fiberoptic bundles. The first ends of each of the bundles have their fibers arranged within a narrow elongated slit, the fibers of each bundle being distributed substantially along the entire length of the slit and further so that the fibers of the bundles are substantially interspersed with one another along said slit. One of the bundles conveys light directed upon the opposite end of the bundle to a surface adjacent said slit and along which the linear motor is moving. The remaining bundle conveys light reflected from the surface to a sensor which converts the intensity of the reflected light into an electrical signal. Changes in the reflectivity of the surface, which may be the etched stator of a linear motor system are utilized to determine the position of the linear motor along the stator. The direction of movement is determined through the utilization of a pair of encoders of the type described wherein the slits of each encoder are arranged in spaced parallel, the spacing being related to the spacing of the pattern on the etched stator to obtain motion and direction detection. Use of a plurality of pairs of encoders having the aforesaid arrangements provides for position, velocity and direction detection as well as rotation detection.
Patent DE-69217924-D1 (DE)
Inventor: JULIN TOMAS
IPC: H04W8/26
Filed: 1992-04-08
Granted: 1997-04-10
Abstract: An apparatus and a method for providing at least two identities to a subscriber unit of a mobile telephone system. A subscriber identity module (SIM) is provided which is inserted into the subscriber unit for selectively activating an identity. The module may be activated through a keypad on the subscriber unit allowing a subscriber to enter a code for selecting a specific identity, or it may be a card having a separate program circuit on either end so that when inserted into the unit with its first end, a first identity is activated, and when inserted into the unit with its second end, a second identity is activated. Each selected identity may be allocated a separate directory number or all identities may be allocated a single number.
Patent DE-69230554-D1 (DE)
Inventor: NGUYEN LE TRONG
IPC: G06F9/30
Filed: 1992-07-07
Granted: 2000-02-17
Abstract: Fast trap mechanism for a microprocessor, wherein a vector trap table is maintained which contains space for a plurality of instructions in each table entry. When a fast trap occurs, control is transferred directly into the table entry corresponding to the trap number. The trap handler can be located completely inside the table entry, or it can transfer control to additional handler code.
Patent DE-69232837-D1 (DE)
Inventor: OSHLACK BENJAMIN
IPC: A61K47/44
Filed: 1992-11-25
Granted: 2002-12-05
Abstract: (A) Controlled release oxycodone formulation for oral admin. to human patients, comprises (i) 10-40mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-60 ng/ml from a mean of 2-4.5 hrs.. After admin., and a mean min. plasma conc. of 3-30 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady state conditions. (ii) 10-160 mg oxycodone or its salt, the formulation providing a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin., and a mean min. plasma conc. from 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions. (B) Also claimed is a solid controlled release oral dosage form comprising (i) oxycodone or its salt in amt. of 10-160 mg; a controlled release matrix selected from hydrophilic hydrophobic polymers, digestible opt. substd. 8-50C hydrocarbons, and/or polyalkylene glycols; and a diluent; wherein the compsn. provides a mean max. plasma conc. of oxycodone of 6-240 ng/ml from a mean of 2-4.5 hrs. after admin, and mean min. plasma conc. of 3-120 ng/ml from a mean of 10-14 hrs. after repeated admin. every 12 hrs. through steady-state conditions; or (ii) an analgesically effective amt. of spheroids comprising oxycodone or its salt and either a spheronising agent or an acrylic polymer or copolymer, such that the total dosage of oxycodone in the dosage form is 10-160 mg; a film coating which controls the release of the oxycodone or its salt at a controlled rate in an aq. medium, wherein the compsn. provides an in vitro dissolution rate of the dosage form.
Patent DE-69331493-D1 (DE)
Inventor: SUNDSTROEM STAFFAN
IPC: A61F7/00
Filed: 1993-03-26
Granted: 2002-03-14
Abstract: PCT No. PCT/DK93/00115 Sec. 371 Date Sep. 26, 1994 Sec. 102(e) Date Sep. 26, 1994 PCT Filed Mar. 26, 1993 PCT Pub. No. WO93/19706 PCT Pub. Date Oct. 14, 1993A heat dressing for treatment of skin areas and comprising a heat generating unit and a liquid-absorbing adhesive layer which prior to use is coated with a strippable release layer. The adhesive layer is preferably of a hydrocolloidal material and may optionally contain one or more medicaments or be coated with alginate fibre mats. The heat generating unit generates heat preferably by means of galvanic or chemical energy, and the heat dressing may further comprise elements for controlling the heat development and/or the surface temperature.
Patent DE-69333109-D1 (DE)
Inventor: DALUGE MARY
IPC: C07D473/00
Filed: 1993-02-24
Granted: 2003-08-28
Abstract: The present invention relates to intermediates useful for the preparation of certain compounds, for example, purine carbocyclic nucleosides.
Patent DE-69333974-D1 (DE)
Inventor: OESTERBERG THOMAS
IPC: A61K9/127
Filed: 1993-10-01
Granted: 2006-04-13
Abstract: This invention relates to a composition comprising coagulation facto Vlll and a non-ionic surfactant as stabilizer and a process for its preparation.
Patent DE-69406936-D1 (DE)
Inventor: DAUER RICHARD
IPC: C07F9/38
Filed: 1994-08-24
Granted: 1998-01-02
Abstract: A process for continuously producing alkylpyrophosphonate, alkylpyrophosphate and multimers thereof and for producing 4-amino-1-hydroxyalkylidene-1,1-bisphosphonic acids or salts thereof.
Patent DE-69409524-D1 (DE)
Inventor: JERATH VIJAY
IPC: C22C38/00
Filed: 1994-06-20
Granted: 1998-05-14
Abstract: PCT No. PCT/GB94/01326 Sec. 371 Date Feb. 22, 1996 Sec. 102(e) Date Feb. 22, 1996 PCT Filed Jun. 20, 1994 PCT Pub. No. WO95/00707 PCT Pub. Date Jan. 5, 1995A rail for use in a railway which has in section, a head having a traffic carrying surface and a foot, wherein the head comprising a traffic carrying surface is composed of low carbon martensite.
Patent DE-69410795-D1 (DE)
Inventor: BATES DARREN
IPC: B01J2/18
Filed: 1994-07-05
Granted: 1998-07-09
Abstract: The invention provides that particles are prepared for use in curable synthetic resin which can be cured selectively. The particles are prepared by filling the curing agent into micropores of the particles using sonic, preferably ultrasonic, energy, and then the particles are dispersed throughout the resin. The curing agent is only released when the resin is subjected to applied energy such as sonic and/or heat energy.
Patent DE-69412734-D1 (DE)
Inventor: DE PIERI TIMOTHY
IPC: E03D1/32
Filed: 1994-09-16
Granted: 1998-10-01
Abstract: The present invention discloses a valve which utilises an imbalance of flow induced pressure forces to keep the valve open or closed. The valve has an interior cavity (15) into which an opposite and aligned inlet (12) and outlet (13) open. A bulbous body (16) is located within the cavity and is reciprocally mounted on a spindle (17) which passes through the outlet. Movement of the body increases the flow area at one end of the body and decreases the flow area at the other end of the body. In accordance with Bernoulli's theory this changes the pressures acting on the body (16) giving rise to a net force on the body. A cistern inlet valve (111, 211) and cistern (19) are also disclosed. <IMAGE>
Patent DE-69416814-D1 (DE)
Inventor: BARR ROBERT K
IPC: G03F7/027
Filed: 1994-10-27
Granted: 1999-04-08
Abstract: Waterborne photoimageable compsn. comprises: (a) 30-80 wt.% of a latex binder polymer including carboxylic acid cpds. giving an acid number of 50-250; (b) 15-50 wt.% of a fraction of alpha, beta-ethylenically unsatd. monomers; (c) 0.1-25 wt.% photoinitiator; (d) 1-40 wt.% of a neutralising base and/or polyether polyurethane associate thickener in amt. to stabilise emulsion of binder; and (e) 0.5-3.0 wt.% of a surfactant of a fluoroaliphatic oxyethylene adduct of formula (I). CF3-(CF2)n-Y-Xm-Z (I); n=0-20; Y = SO2-N (1-10C) alkyl; X = CH2-CH2-O or CH(CH3)-CH2-O; m=0-20; and Z= CH2-CH2-OH or CH(CH3)-CH2OH. Also claimed is a support sheet and layer of the compsn. above forming a dry film.
Patent DE-69418186-D1 (DE)
Inventor: KRALOVIC RAYMOND
IPC: A61L11/00
Filed: 1994-02-25
Granted: 1999-06-02
Abstract: A bag (86) of medical wastes is inserted into a chamber (12) that contains a grinder (20). A package (48) is placed unopened in the chamber with the medical wastes. A selected volume of a dilutant such as water is added to the chamber (40, 42). The chamber is closed and the grinder operated for a selected duration. The grinder grinds the packaging, disposing of the packaging and permitting contained dry reagents (56, 58) such as acetylsalicylic acid and perborate to react with the dilutant, forming a peracetic acid solution or permitting a sterilant concentrate (70) to form an anti-microbial solution with the dilutant. The grinder continues to grind the packaging and the medical wastes into fine particulates forming a slurry with the peracetic acid solution. The continued operation of the grinder assures that the anti-microbial solution contacts all surfaces of the waste. In this manner, the medical wastes are microbially decontaminated. A color indicator (60, 78) is included with the packaging to provide a color indication as to whether the anti-microbial reaction is complete. For example, a Gentian Violet may be provided which fades to white to indicate completion of the decontamination process. Once decontaminated, the slurry is removed from the chamber and disposed of as non-contaminated waste materials. Optionally, fragrances and deodorants may be included in the package.
Patent DE-69419357-D1 (DE)
Inventor: TOKUDA TOSHIMASA
IPC: C08G64/14
Filed: 1994-04-26
Granted: 1999-08-12
Abstract: A modified aromatic polycarbonate resin containing at least one substituted phenyloxy group of the formula (I) in an amount of at least 5 mol% of the total amount of terminals, <CHEM>     wherein: X is a halogen atom or a monovalent aliphatic hydrocarbon group having 1 to 10 carbon atoms,     p is an integer of 0 to 4, and     Q is <CHEM>     or <CHEM> The present invention provide a modified aromatic polycarbonate resin of which the melt fluidity and electric properties are improved without impairing the excellent properties inherent to a polycarbonate resin such as transparency, heat resistance and dimensional stability.
Patent DE-69422290-D1 (DE)
Inventor: BURTON JOHN
IPC: A61F7/12
Filed: 1994-06-24
Granted: 2000-01-27
Abstract: A device for dilating at least an obstructed portion of a urethra includes a hollow core member with opposed open ends permitting urination therethrough from the bladder, a confining covering disposed on the hollow member having a length of at least that of the obstructed portion and having hydrophilic means integrally associated therewith. The hydrophilic means is capable of absorbing water and gradually expanding for at least 30 minutes whereby the outer surface of the confining covering expands radially and outwardly, after insertion into the urethra, until dilation of the obstructed portion occurs to a desired diameter and configuration. Methods for dilating an obstructed portion of the urethra and for treating benign prostatic hyperplasia are also provided.
Patent DE-69504865-D1 (DE)
Inventor: DESAIX JEAN-CLAUDE
IPC: C08F8/46
Filed: 1995-11-20
Granted: 1998-10-22
Abstract: Bitumen compositions comprising bitumen and at least one succinic anhydride derivative contained in the bitumen, processes for their preparation and their use in bitumen emulsions for road applications, e.g. surface dressings.
Patent DE-69506192-D1 (DE)
Inventor: EMAMBAKHSH AL S
IPC: B60R21/26
Filed: 1995-07-24
Granted: 1999-01-07
Abstract: A vehicle occupant restraint system comprises an inflatable air bag (12), an air bag canister (24) having walls defining an interior chamber (25) in which the air bag is stored, and a source of inflation fluid (20) for inflating the air bag. The source of inflation fluid includes (i) an inflator body (21) having opposite ends and (ii) a nozzle opening (23) disposed at one end of the inflator body. A deflector panel (50) is attached to the air bag. The deflector panel defines an opening (45) through which inflation fluid flows to inflate the air bag. The deflector panel has surfaces (71, 72) that deflect inflation fluid flow from the nozzle opening (23) and through the opening (45). <MATH>
Patent DE-69508194-D1 (DE)
Inventor: BOLMER MICHAEL SHEPPARD
IPC: B01J27/132
Filed: 1995-09-12
Granted: 1999-04-15
Abstract: Process for synthesizing 1,1,1-trifluoroethane (143a) in the gaseous phase by reacting 1,1-defluoro-1-chloroethane in gaseous phase in the presence of a Cr catalyst. The process may be run isothermally or adiabatically, without co-feeding air or other oxygen containing gas, in the presence or absence of a Ni, Co, Zn or Mn cocatalyst for the Cr catalyst. The catalyst may be unsupported or supported with a support preferably selected from activated carbon, alumina and fluorided alumina. The formation of olefin byproduct can be kept to less than 10 ppm in accordance with the process of the invention.
Patent DE-69509516-D1 (DE)
Inventor: CHAUDHARY BHARAT
IPC: C08J9/12
Filed: 1995-02-10
Granted: 1999-06-10
Abstract: An uncrosslinked, closed cell, low density ethylenic polymer foam having a density of less than 150 kg/m3 is prepared from, for example, uncrosslinked low density polyethylene using inorganic blowing agents, such as carbon dioxide, argon, or mixtures thereof. A process for preparing such uncrosslinked, closed cell, low density ethylenic polymer foam comprising extruding a ethylenic polymer of suitable melt tension using a 100 percent inorganic blowing agent, such as carbon dioxide, argon, or mixtures thereof, and the foams produced with this process are also disclosed.
Patent DE-69518307-D1 (DE)
Inventor: COUSSEAU PIERRE
IPC: B65D17/40
Filed: 1995-03-16
Granted: 2000-09-14
Abstract: The cylindrical grease polythene cartridge for use in a distributing gun has a tubular body (1) closed at one end by a bottom (2) moulded with cartridge side wall. Its other end is sealed by a removable plug. A connection zone of least resistance (4) is provided between the bottom periphery and the end of the tubular body. This zone is formed by a circular groove whose depth is equal to a fraction of the thickness of the bottom. A gripping ring (5) connected to the bottom enables easy separation of the bottom along the whole of its surface before use in the gun to obtain a smooth passage through which the grease can flow. Inside the connecting zone, in the radial direction, is a second zone (6) of least resistance, concentric with the first, so as to form between them a circular tearable band (7). These external and internal zones are connected by radial connecting zones of least resistance (9), directed towards the bottom centre, forming a tearing band (10'), whose end is connected to the gripping ring.
Patent DE-69520037-D1 (DE)
Inventor: JOHN MICHEL
IPC: A63B63/00
Filed: 1995-05-18
Granted: 2001-03-08
Abstract: PCT No. PCT/GB95/01120 Sec. 371 Date Aug. 26, 1996 Sec. 102(e) Date Aug. 26, 1996 PCT Filed May 18, 1995 PCT Pub. No. WO95/32031 PCT Pub. Date Nov. 30, 1995A goalpost comprises a frame 10 on which is located a net 38. The frame 10 is movable between an assembled position as shown and a folded position, and comprises six lengths of tubing 12, 14, 16, 18, 20, 22, each length of tubing having a first end and a second end, the second end of the first length of tubing being connected to the first end of the second length of tubing and so on with the second end of the nth length of tubing being connected to the first end of the first length of tubing to form a closed circuit; a connector 24, 26, 28, 30, 32, 34 between each of the first end of a length of tubing and the second end of an adjacent length of tubing, the connectors being designed to permit two adjacent lengths of tubing to be arranged at a first angle to each other in the assembled position of the frame as shown and a second angle to each other in the folded position of the frame; and tensioning means, such as a continuous elastic cord, between each pair of adjacent lengths of tubing to hold the lengths of tubing and the connectors in position in the assembled position of the frame and to permit the frame to be moved between its assembled position and its folded position.
Patent DE-69520725-D1 (DE)
Inventor: DENSON KENNETH WILLIAM ERNEST
IPC: G01N33/86
Filed: 1995-06-09
Granted: 2001-05-23
Abstract: A method and kit for screening blood plasma for APC cofactor is provided. The method comprises:     (i) incubating a first portion of the sample with   (a) an exogenous reagent containing phospholipid which activates the contact mechanism in intrinsic clotting or an exogenous reagent which initiates extrinsic clotting; and incubating a second portion of the sample with (b) the reagent of step (i) (a) and an exogenous Protein C (PC) activator which produces activated PC (APC) from endogenous Protein C and Protein S.   (ii) adding to each of the two portions a clotting agent and monitoring the conversion rate of fibrinogen to insoluble fibrin; and   (iii) calculating the ratio of the rate for the second portion of the sample to the rate for the first portion and comparing this ratio with the corresponding ratio for samples from normal subjects.
Patent DE-69529911-D1 (DE)
Inventor: LINDSKOG SVEN
IPC: A61K6/40
Filed: 1995-09-14
Granted: 2003-04-17
Abstract: PCT No. PCT/SE95/01041 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Sep. 14, 1995 PCT Pub. No. WO96/09029 PCT Pub. Date Mar. 28, 1996A composition for use in biological, mineralized surface conditioning, especially tooth root conditioning, by selective removal of parts of an exposed tooth root surface so as to improve subsequent attachment of the tooth in conjunction with periodontal surgery, includes, as an active constituent, an effective amount of ethylene-diaminotetraacetic acid (EDTA) in combination with an aqueous matrix. A method of tooth root conditioning includes, in a preferred embodiment, the step of applying to an exposed tooth root surface a viscous composition of EDTA in a concentration of no less than 80% by weight of the concentration at saturation of EDTA.
Patent DE-69602529-D1 (DE)
Inventor: NITSAS FOTIOS
IPC: A23L27/12
Filed: 1996-06-27
Granted: 1999-06-24
Abstract: PCT No. PCT/GR96/00016 Sec. 371 Date Dec. 29, 1997 Sec. 102(e) Date Dec. 29, 1997 PCT Filed Jun. 27, 1996 PCT Pub. No. WO97/01348 PCT Pub. Date Jan. 16, 1997Methods for treating and preventing coccidiosis in poultry, and inflammation, infection, and diarrhea in mammals are provided utilizing an antimicrobial pharmaceutical composition comprising an herbal essential oil which contains thymol and carvacrol as its main ingredients. The essential oil is preferably obtained from the genus Origanum, especially Origanum vulgare ssp. hirtum.
Patent DE-69603699-D1 (DE)
Inventor: SKJOLSTRUP CARL ERIK
IPC: B25J5/04
Filed: 1996-01-05
Granted: 1999-09-16
Abstract: The present invention concerns a robot system (1) for automated performance of working operations in open structures (17) in the heavy industries, comprising a portal structure (2) having at least two parallel longitudinal girders (3) provided with travelling paths (4) (X direction) to support engagement parts (10) at each end of at least one transverse robot gantry (9), which comprises a carrier girder (12) having travelling paths (13) (Y direction) to support engagement parts (14) on a robot arm (15), said robot arm (15) having an upper end which may be advanced at a maximum height (L) above the carrier girder (12), as well as a lower part which may move in an upward and downward direction (Z direction), and which has a lower working head (16) to perform said operations. The system is characterized in that the carrier girder (12) of the gantry (9) is provided at a distance below the upper side of the longitudinal girders (3), said distance corresponding at least to the maximum height (L) of the robot arm above the carrier girder (12).